These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22948427)

  • 1. [Aspirin in the primary prevention of colorectal cancer].
    Fernández Calderón M; Betés Ibáñez MT
    An Sist Sanit Navar; 2012; 35(2):261-7. PubMed ID: 22948427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and NSAIDs for the prevention of colorectal cancer.
    Baron JA
    Recent Results Cancer Res; 2009; 181():223-9. PubMed ID: 19213572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: weighing the evidence.
    Stürmer T; Buring JE; Glynn RJ
    Ann Intern Med; 2007 Nov; 147(9):674; author reply 674-5. PubMed ID: 17975195
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents.
    Greenberg ER; Baron JA
    IARC Sci Publ; 1996; (139):91-8. PubMed ID: 8923021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
    Dubé C; Rostom A; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
    Ann Intern Med; 2007 Mar; 146(5):365-75. PubMed ID: 17339622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aspirin and NSAIDs on colorectal adenomas. Protective effect may be spurious.
    Lo SV; Perry HU; Lyons R
    BMJ; 1993 Sep; 307(6906):734. PubMed ID: 8401104
    [No Abstract]   [Full Text] [Related]  

  • 9. Colorectal cancer and nonsteroidal anti-inflammatory drugs.
    Smalley WE; DuBois RN
    Adv Pharmacol; 1997; 39():1-20. PubMed ID: 9160111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.
    Cuzick J; Otto F; Baron JA; Brown PH; Burn J; Greenwald P; Jankowski J; La Vecchia C; Meyskens F; Senn HJ; Thun M
    Lancet Oncol; 2009 May; 10(5):501-7. PubMed ID: 19410194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
    DuBois RN; Giardiello FM; Smalley WE
    Gastroenterol Clin North Am; 1996 Dec; 25(4):773-91. PubMed ID: 8960892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E; Rothwell PM;
    Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence.
    Weiss HA; Forman D
    Scand J Gastroenterol Suppl; 1996; 220():137-41. PubMed ID: 8898452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summaries for patients. Aspirin or nonsteroidal anti-inflammatory drugs for the prevention of colorectal cancer: U.S. Preventive Services Task Force recommendations.
    Ann Intern Med; 2007 Mar; 146(5):I35. PubMed ID: 17339615
    [No Abstract]   [Full Text] [Related]  

  • 16. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H; Arber N
    Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
    Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are aspirin and other non-steroidal anti-inflammatory drugs effective in the prevention and treatment of colorectal cancer?
    Elder DJ; Paraskeva C
    Lancet; 1996 Aug; 348(9025):485. PubMed ID: 8709821
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevention of colorectal cancer by aspirin use.
    Giovannucci E
    Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.